Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 2
Encontrada(s) 1 página(s)

RUC. Repositorio da Universidade da Coruña
Publicación Artículo científico (JournalArticle)

Encapsulation of Transforming Growth Factor-β3 in Poly(hydroxybutyrate-co-hydroxyvalerate) Nanoparticles for Enhanced Cartilage Tissue Engineering

  • Rodríguez-Cendal, Ana Isabel
  • Señarís-Rodríguez, José
  • Piñeiro-Ramil, María
  • Cabarcos Mouzo, Loreto
  • Veiga-Barbazán, María del Carmen
  • Meijide-Faílde, Rosa
  • De-Toro, Javier
  • Fuentes Boquete, Isaac Manuel
  • Díaz-Prado, Silvia
[Abstract] Poly(hydroxybutyrate-co-hydroxyvalerate) (PHBV) is a naturally occurring biopolymer belonging to the polyhydroxyalkanoate (PHA) family. Due to its excellent properties (biocompatible, biodegradable, and non-toxic), this biopolymer is presented as a very suitable option for use in regenerative therapy as a drug delivery system (DDS). The protein encapsulated in this study is transforming growth factor β3 (TGF-β3), which plays a key role in the chondrogenic differentiation of mesenchymal stem cells (MSCs). The main objective of this work is to evaluate the efficacy of PHBV nanoparticles (NPs) produced from a dairy by-product (whey) as a DDS of TGF-β3 for cartilage regeneration and extracellular matrix (ECM) synthesis and to reduce the complications associated with multiple high doses of TGF-β3 in its free form. For this purpose, biopolymer cytotoxicity, factor release, cell viability, cell proliferation, and differentiation were analyzed. The results showed that the biomaterial purified with chloroform and ethanol, either by single or double precipitation, was not toxic to cells. A sustained release profile was observed, reaching its maximum around day 4. The TGF-β3 NPs promoted the differentiation of MSCs into chondrocytes and the formation of ECM. In conclusion, PHBV demonstrated its potential as an optimal material for DDSs in cartilage regenerative therapy, effectively addressing the key challenge of the need for a single delivery method to reduce complications associated with multiple high doses of TGF-β3., Instituto de Salud Carlos III—General Subdirection of Assessment and Promotion of Research—European Regional Development Fund (FEDER) “A way of making Europe” (PI20/00933) and the Spanish Ministry of Economy and Competitiveness (MINECO) through European FEDER funds (PID2023-151067OB-I00), ayudas para proyectos Semilla-Disruptivos entre grupos del CICA 2021 (POLIBIOMED) of Universidade da Coruña, Grupos con Potencial de Crecemento (ED431B 2020/55 and ED431B 2023/58), Grupos de Referencia Competitiva (ED431C 2021/55) of Xunta de Galicia, and proyectos de Desarrollo y Transferencia 2022 and 2024 of Fundación Pública Gallega de Investigación Biomédica (INIBIC). A.I.R.-C. is currently employed by the Grupos con Potencial de Crecemento, Xunta de Galicia project (ED431B 2023/58).
RUC. Repositorio da Universidade da Coruña
Publicación Artículo científico (JournalArticle)

Tips and tricks for successfully culturing and adapting human induced pluripotent stem cells

  • Castro Viñuelas, Rocío
  • Sanjurjo-Rodríguez, Clara
  • Piñeiro-Ramil, María
  • Rodríguez-Fernández, Silvia
  • López-Baltar, Isidoro
  • Fuentes Boquete, Isaac Manuel
  • Blanco García, Francisco J
  • Díaz-Prado, Silvia
Protocol, [Abstract] Reprogramming somatic cells toward pluripotency became possible over a decade ago. Since then, induced pluripotent stem cells (iPSCs) have served as a versatile and powerful tool not only for basic research but also with the long-term goal of using them in human cell transplantation after differentiation. Nonetheless, downstream applications are frequently blurred by the difficulties that researchers have to face when working with iPSCs, such as trouble with clonal selection, in vitro culture and cryopreservation, adaptation to feeder-free conditions, or expansion of the cells. Therefore, in this article we aim to provide other researchers with practical and detailed information to successfully culture and adapt iPSCs. Specifically, we (1) describe the most common problems when in-vitro culturing iPSCs onto feeder cells as well as its possible troubleshooting, and (2) compare different matrices and culture media for adapting the iPSCs to feeder-free conditions. We believe that the troubleshooting and recommendations provided in this article can be of use to other researchers working with iPSCs and who may be experiencing similar issues, hopefully enhancing the appeal of this promising cell source to be used for biomedical investigations, such as tissue engineering or regenerative medicine applications., We thank the laboratory staff from INIBIC-CHUAC, the Radio Physics department from the Oncology Center of Galicia and the Servicio de Xenética (CHUAC) for their assistance. We also thank the staff from Oza University Library (University of A Coruña) for their collaboration. We also thank our funding agencies: Instituto de Salud Carlos III-General Subdirection of Assessment and Promotion of the Research—European Regional Development Fund (FEDER) “A way of making Europe” (PI17/02197 and PI20/00933); Rede Galega deTerapia Celular and Grupos con Potencial de Crecemento, Xunta de Galicia (R2016/036, R2014/050, CN2012/142, ED431B 2020/55, and GPC2014/048); the University of A Coruña; M.P.-R. and S.R.-F. are granted by a predoctoral fellowship from Xunta de Galicia and European Union (European Social Fund) and C.S.-R. was beneficiary of a postdoctoral fellowship from Xunta de Galicia, Xunta de Galicia; R2016/036, Xunta de Galicia; R2014/050, Xunta de Galicia; CN2012/142, Xunta de Galicia; ED431B 2020/55, Xunta de Galicia; GPC2014/048